Author:
Roska Botond,Sahel José-Alain
Publisher
Springer Science and Business Media LLC
Reference132 articles.
1. The Lasker Foundation. Restoring Vision to the Blind
http://www.laskerfoundation.org/new-noteworthy/articles/restoring-vision-blind/
(2015).
2. Olson, R. J. Cataract surgery from 1918 to the present and future—just imagine! Am. J. Ophthalmol. 185, 10–13 (2017).
3. Jager, R. D., Mieler, W. F. & Miller, J. W. Age-related macular degeneration. N. Engl. J. Med. 358, 2606–2617 (2008).
4. Hodgson, N. et al. Economic and quality of life benefits of anti-VEGF therapy. Mol. Pharm. 13, 2877–2880 (2016).
5. Finger, R. P., Guymer, R. H., Gillies, M. C. & Keeffe, J. E. The impact of anti-vascular endothelial growth factor treatment on quality of life in neovascular age-related macular degeneration. Ophthalmology 121, 1246–1251 (2014).